CSClaudia Sicher

Claudia Sicher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Claudia Sicher has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Georg Daeschlein

    Department of Dermatology, University Medicine Greifswald, Greifswald, Germany

    2 shared publications
  • Rico Rutkowski

    Department of Oral and Maxillofacial Surgery/Plastic Surgery, University Medicine Greifswald, Greifswald, Germany

    2 shared publications
  • Sebastian von Podewils

    Department of Dermatology, University Medicine Greifswald, Greifswald, Germany

    2 shared publications
  • Anne Hillmann

    Department of Dermatology, University Medicine Greifswald, Sauerbruchstra_e, 17475 Greifswald, Germany

    1 shared publication
  • Denis Gümbel

    Department of Orthopedics, Trauma Surgery and Rehabilitative Medicine, University Medicine Greifswald, 17471 Greifswald, Germany

    1 shared publication
  • Georg Daeschlein

    Klinik und Poliklinik für Hautkrankheiten, Universitätsmedizin Greifswald, Sauerbruchstr. 1-4, 17475, Greifswald, Deutschland.

    1 shared publication

Latest Publications

  • Hyperspectral imaging as a possible tool for visualization of changes in hemoglobin oxygenation in patients with deficient hemodynamics – proof of concept

    by Claudia Sicher, Rico Rutkowski, Stine Lutze, Sebastian von Podewils, Thomas Wild, Markus Kretching, Georg Daeschlein

    There is a lack of imaging tools for the evaluation of spatial alterations in microcirculation including blood oxygen saturation and hemoglobin distribution but recent innovative developments in hyperspectral technology may offer a solution. We examined different hemodynamic disorders in patients suffering from scleroderma, Dupuytren surgery, chronic foot ulcera and skin infections. Superficial and deeper blood oxygen saturation, hemoglobin distribution and water content were determined using hyperspectral imaging (HSI). In the patient with scleroderma, distinct cutaneous low perfused regions correlated with macroscopic skin aspects and seem to be potential therapy control marker. With HSI accurate clinical evaluation of a macroscopic conspicuous wound after Dupuytren surgery was possible and influenced further surveillance decisions. HSI clearly revealed the spatial geometry and also the clinically related perfusion parameters of abscess formation and chronic ulcer wounds. The hemodynamically relevant parameters like blood oxygen saturation (1 mm to approx. 6 mm subcutaneous), total hemoglobin distribution and tissue water content can be easily determined and visualized with HSI in near real time. Hence, this technique seems to be suitable for routine diagnostics of acute and chronic wounds as well as for the examination of systemic hemodynamic disturbances. Special indications may be transplant surveillance and monitoring of therapeutical interventions.


  • Plasma Cancer Therapy In Dermatology

    by Georg Daeschlein, Claudia Sicher, Sebastian von Podewils, Rico Rutkowski, Michael Jünger

  • Enhanced Anticancer Efficacy by Drug Chemotherapy and Cold Atmospheric Plasma Against Melanoma and Glioblastoma Cell Lines In Vitro

    by Georg Daeschlein, Anne Hillmann, Denis Gumbel, Claudia Sicher, Sebastian von Podewils, Matthias B. Stope, Michael Junger

    Cold atmospheric plasma (CAP) interacting with tumor cells and finally leading to selective cell death has opened new horizons in cancer therapy. Despite significant progress in modern cancer treatment using immunologic and targeted therapies melanoma and glioblastoma presenting as brain metastases or primary tumor with poor prognosis are still a therapeutic challenge. The aim of the current study was to evaluate the potential of CAP (indirect treatment) in combination with the chemotherapeutics bleomycin, paclitaxel and dacarbazine to inhibit proliferation on human melanoma and glioblastoma cells in vitro. Cell lines of mouse melanoma (B16) were exposed for 1, 4, 12, 24 and 48 h, and of human melanoma (A375) and glioblastoma (A172) for 24 h to bleomycin, dacarbazine and paclitaxel together with plasma activated PBS. Directly after exposure cell proliferation after single (CAP, chemotherapeutic) or combined (CAP plus chemotherapeutic) treatment was assessed by cytotoxicity assay. Indirect CAP treatment of cell lines of glioblastoma and melanoma was followed by a strong reduction of proliferation most prominent after 24 h and 48 h exposure. With all drugs maximal reduction was achieved when drug-CAP combinations were used. Combination with CAP treating B16 melanoma cells reached 98% (48 h, combined with paclitaxel), A375 melanoma cells 82% (24 h, combined with bleomycin) and glioblastoma cells 96% (24 h, combined with paclitaxel). The combination of chemotherapy with CAP as indirect treatment may be beneficial in therapy of melanoma and glioblastoma by enhanced tumor reduction and less drug toxicity of chemotherapeutics.